14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Wednesday, 17th Aug 2022 PTIE stock ended at $40.17. During the day the stock fluctuated 0% from a day low at $40.17 to a day high of $40.17.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Pain Therapeutics prices

Date Open High Low Close Volume
Jan 29, 2016 $11.34 $11.69 $11.20 $11.34 4 614
Jan 28, 2016 $11.69 $11.83 $11.27 $11.27 871
Jan 27, 2016 $11.55 $11.97 $11.48 $11.62 4 743
Jan 26, 2016 $11.34 $11.97 $11.06 $11.48 3 786
Jan 25, 2016 $11.34 $11.97 $10.99 $11.27 9 543
Jan 22, 2016 $11.34 $11.62 $10.99 $11.20 8 214
Jan 21, 2016 $11.55 $11.76 $10.85 $11.27 21 257
Jan 20, 2016 $11.41 $11.97 $10.99 $11.97 14 557
Jan 19, 2016 $11.69 $11.90 $11.41 $11.48 9 114
Jan 15, 2016 $11.41 $11.62 $10.92 $11.62 9 571
Jan 14, 2016 $11.55 $11.76 $11.55 $11.62 4 729
Jan 13, 2016 $11.76 $11.97 $11.41 $11.62 6 700
Jan 12, 2016 $11.83 $12.11 $11.62 $11.69 9 257
Jan 11, 2016 $12.25 $12.39 $11.41 $11.69 17 771
Jan 08, 2016 $12.25 $12.32 $12.04 $12.25 17 614
Jan 07, 2016 $12.25 $12.46 $11.90 $12.25 12 500
Jan 06, 2016 $12.39 $12.74 $12.04 $12.39 4 429
Jan 05, 2016 $12.32 $12.60 $12.04 $12.53 4 343
Click to get the best stock tips daily for free!

About Pain Therapeutics

Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The company’s lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimer’s disease and other neurological disorders. The company was founded i... PTIE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT